IRX 5010
Alternative Names: IRX-5010Latest Information Update: 15 Jul 2024
At a glance
- Originator Io Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Retinoic acid receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Breast cancer